Timmi Stump

Timmi Stump

Chief Commercial OfficerOfficers & Management Team

Timmi Stump is a seasoned Sales and Marketing executive with extensive experience in the biotech and pharmaceutical industries. As Chief Commercial Officer (CCO) of Vesalius, she is at the forefront of driving the company's commercial strategy, market expansion, and revenue growth in an era of transformative health innovation. With a deep understanding of diagnostics, biotechnology, and pharmaceuticals, Timmi plays a pivotal role in ensuring that Vesalius' groundbreaking products reach the right markets while maintaining the company's commitment to integrity, transparency, and thought leadership.

In her role, Timmi leads Vesalius' global commercial operations, overseeing sales, marketing, market access, and customer engagement strategies. She is responsible for building and scaling a high-performing commercial organization that effectively aligns with the company's mission to deliver the highest-quality products and customer experience. Her expertise in sales effectiveness and business development enables Vesalius to forge strategic partnerships with key stakeholders, including healthcare providers, payers, and regulatory agencies, ensuring widespread adoption and accessibility of the company's innovative solutions.

Timmi also spearheads brand strategy and market positioning efforts, ensuring that Vesalius remains a leader in the competitive biotech landscape. Under her leadership, the company is poised to expand into new markets, optimize go-to-market strategies, and develop robust commercial frameworks that drive sustained growth. By leveraging data-driven insights, customer-centric approaches, and her vast industry network, she fosters a culture of commercial excellence that accelerates Vesalius' impact on global health.

Back to Leadership

Disclaimer: The information provided on this website is intended for general educational and informational purposes only. Vesalius Longevity Labs provides information relating to peptide science, longevity, wellness, metabolic health, and emerging areas of medical research.

FDA Approval & Investigational Therapies: Not all peptides, compounds, medications, or therapies discussed or referenced on this website are approved by the U.S. Food and Drug Administration (FDA). Certain compounds may be investigational, have limited clinical evidence, or lack established long-term safety and efficacy data. References to scientific research, emerging therapies, or potential health benefits are provided for informational purposes and should not be interpreted as claims of FDA approval, established clinical effectiveness, or guaranteed therapeutic outcomes. Where legally permitted, certain medications may be compounded by appropriately licensed pharmacies in accordance with applicable federal and state laws. Compounded medications are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing in the same manner as FDA-approved medications. Read the full disclaimer.